Eli Lilly
NYSE:LLY Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 440 Fair Values set on narratives written by author
WA
Consensus Narrative from 26 Analysts
Calculated R&D And Acquisitions Propel Growth Amid Strong Demand For Innovative Therapies
Key Takeaways Strategic expansions and acquisitions, along with R&D investments, aim to drive long-term growth and revenue through product innovation and enhanced manufacturing. Strong demand for key products and pipeline milestones are positioned to enhance revenue and expand the company's therapeutic offerings, boosting future earnings potential.
View narrativeUS$974.93
FV
10.4% undervalued intrinsic discount23.85%
Revenue growth p.a.
6users have liked this narrative
0users have commented on this narrative
98users have followed this narrative
23 days ago author updated this narrative